POB3 COST-UTILITY ANALYSIS OF RIMONABANT IN THE TREATMENT OF OBESITY
Abstract
Authors
C Hampp AG Hartzema
C Hampp AG Hartzema
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now